Dr. James Carter sat stiffly in the backseat, his heart pounding like a war drum.

Ethan Perez—his missing patient—was right in front of him. But he wasn’t the same man Carter had seen in medical records.

His skin was pale, almost sickly, with dark veins visible beneath the surface. His hands shook subtly, as if his nervous system was slowly failing.

And his eyes—they looked haunted.

Carter swallowed hard. "What do you mean? It’s in all of them?"

Ethan exhaled, rubbing a trembling hand over his face.

“You think this is about one bad batch of Vibramycin?” He gave a bitter chuckle. “No, Doc. It’s the entire supply. Every pill, every bottle, every damn prescription pad across the country.”

Carter’s stomach clenched. “That’s not possible.”

Lena, still catching her breath, leaned forward. “If it’s everywhere, then why aren’t millions of people affected?”

Ethan’s jaw tightened. “Because it’s slow.”

A Deliberate Poison

Lena’s breath hitched. “You mean it accumulates?”

Ethan nodded. “A microdose in every pill. Barely noticeable at first. It takes weeks—months, even—to start showing symptoms. Fatigue, blurred vision, a little brain fog—things that could be blamed on anything.”

Carter’s mind reeled. That explained why some of his patients had symptoms, but not all.

“You don’t notice it right away,” Ethan continued, “because it’s meant to blend in with normal side effects.”

Lena pressed a hand to her forehead. “Jesus. That’s why no one’s reported it. If people think it’s just a rare reaction to the drug, they won’t question it.”

Carter’s fingers tightened into a fist. “What’s in it, Ethan? We tested the pills—we found a neurotoxin.”

Ethan’s expression darkened. “It’s not just a neurotoxin.”

He pulled something from his pocket. A single, white pill. He held it up in the dim light of the parking garage.

“This,” he said, “isn’t Vibramycin. Not really.”

Carter’s blood ran cold.

“What is it?”

Ethan’s lips pressed into a thin line. “It’s a test.”

The Vibramycin Experiment

Lena’s head snapped up. “A test for what?”

Ethan hesitated. “Look, I don’t know everything. But I know this—Genova Biotech isn’t just making antibiotics.”

Carter clenched his jaw. “They’re testing something.”

Ethan nodded. “Yeah. And they’re using us—normal, everyday patients—as their clinical trial.”

Lena stared at the pill in Ethan’s hand, then at the sample Carter had brought her.

“This isn’t a contamination issue,” she murmured. “This was intentional.”

Ethan’s fingers curled around the pill. “And that means there’s only one question that matters.”

He looked up, his tired, haunted eyes meeting Carter’s.

“What exactly are they testing on us?”

A New Target: Genova Biotech

Silence hung thick in the car.

Carter felt like the ground had just shifted beneath him.

Vibramycin 100 mg wasn’t just tainted. It wasn’t just dangerous.

It was a mass experiment.

Lena spoke first, her voice steady despite the fear in her eyes.

“Then we have to go to Genova Biotech.”

Ethan let out a short laugh. “Yeah? And do what, exactly? Walk in and ask them politely to explain?”

Carter’s voice was firm. “No. We need proof. Hard evidence. Something we can take to the press—to the authorities.”

Ethan shook his head. “You still don’t get it, do you?”

His voice dropped lower, quieter.

“They already know.”

Carter’s breath stalled.

Ethan leaned forward, eyes sharp. “You think the FDA doesn’t know? You think no one inside the government has seen this?”

Lena’s face paled. “If they know… and they’re not stopping it… that means—”

Ethan finished the thought for her.

“It means they’re letting it happen.”

Carter exhaled sharply. His hands clenched into fists.

They weren’t dealing with a single rogue company.

They were up against something bigger.

And now—it knew they were coming.